BRAIN Act

The BRAIN Act (HR 9113) establishes new research networks and funding mechanisms to advance brain tumor treatment and care. It requires the NIH to create a searchable database of brain tumor biospecimens, authorizes $50 million annually for a Glioblastoma Therapeutics Network, and allocates $10 million yearly for CAR-T cell therapy research. The bill also mandates a national awareness campaign about clinical trials and biomarker testing, and funds pilot programs to improve long-term care for brain tumor survivors. These provisions directly affect researchers, patients, healthcare providers, and survivors, with funding allocated for fiscal years 2026 through 2030.